tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Balanced Outlook on Bristol-Myers Squibb: Hold Rating Amid Strong Immuno-Oncology Growth and Pipeline Uncertainties
PremiumRatingsBalanced Outlook on Bristol-Myers Squibb: Hold Rating Amid Strong Immuno-Oncology Growth and Pipeline Uncertainties
1d ago
Bristol-Myers Squibb Reports Q3 2025 Financial Results
Premium
Company Announcements
Bristol-Myers Squibb Reports Q3 2025 Financial Results
1d ago
Bristol Myers reports Q3 adjusted EPS $1.63, consensus $1.52
Premium
The Fly
Bristol Myers reports Q3 adjusted EPS $1.63, consensus $1.52
1d ago
Hold Rating for Bristol-Myers Squibb Amid Fair Valuation and Mixed Growth Prospects
PremiumRatingsHold Rating for Bristol-Myers Squibb Amid Fair Valuation and Mixed Growth Prospects
4d ago
Bristol Myers’ Sotyktu shows efficacy in arthritis and SLE
Premium
The Fly
Bristol Myers’ Sotyktu shows efficacy in arthritis and SLE
4d ago
Bristol Myers announces updated data from Phase 1 study of CD19
Premium
The Fly
Bristol Myers announces updated data from Phase 1 study of CD19
5d ago
Bristol Myers, SystImmune report global Phase 1 results of Iza-bren
PremiumThe FlyBristol Myers, SystImmune report global Phase 1 results of Iza-bren
14d ago
Neutral Outlook for Bristol-Myers Squibb Amidst Competitive Pressures and Growth Challenges
Premium
Ratings
Neutral Outlook for Bristol-Myers Squibb Amidst Competitive Pressures and Growth Challenges
15d ago
insitro, Bristol Myers extend ALS research collaboration
Premium
The Fly
insitro, Bristol Myers extend ALS research collaboration
17d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100